BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 21765617)

  • 1. Flavocoxid inhibits phospholipase A2, peroxidase moieties of the cyclooxygenases (COX), and 5-lipoxygenase, modifies COX-2 gene expression, and acts as an antioxidant.
    Burnett BP; Bitto A; Altavilla D; Squadrito F; Levy RM; Pillai L
    Mediators Inflamm; 2011; 2011():385780. PubMed ID: 21765617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis.
    Pallio G; Bitto A; Pizzino G; Galfo F; Irrera N; Minutoli L; Arcoraci V; Squadrito G; Macrì A; Squadrito F; Altavilla D
    Eur J Pharmacol; 2016 Oct; 789():152-162. PubMed ID: 27450484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages.
    Altavilla D; Squadrito F; Bitto A; Polito F; Burnett BP; Di Stefano V; Minutoli L
    Br J Pharmacol; 2009 Aug; 157(8):1410-8. PubMed ID: 19681869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis.
    Polito F; Bitto A; Irrera N; Squadrito F; Fazzari C; Minutoli L; Altavilla D
    Br J Pharmacol; 2010 Nov; 161(5):1002-11. PubMed ID: 20977452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethyl ester of bilirubin exhibits anti-inflammatory activity through inhibition of secretory phospholipase A2, lipoxygenase and cyclooxygenase.
    Joshi V; Umashankara M; Ramakrishnan C; Nanjaraj Urs AN; Suvilesh KN; Velmurugan D; Rangappa KS; Vishwanath BS
    Arch Biochem Biophys; 2016 May; 598():28-39. PubMed ID: 27060751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
    Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
    J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.
    Altavilla D; Minutoli L; Polito F; Irrera N; Arena S; Magno C; Rinaldi M; Burnett BP; Squadrito F; Bitto A
    Br J Pharmacol; 2012 Sep; 167(1):95-108. PubMed ID: 22471974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the medical food flavocoxid [corrected] in managing osteoarthritis.
    Gottlieb D; Kuritzky L
    J Pain Palliat Care Pharmacother; 2011; 25(1):49-54. PubMed ID: 21426218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
    Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
    Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celastrol modulates inflammation through inhibition of the catalytic activity of mediators of arachidonic acid pathway: Secretory phospholipase A
    Joshi V; Venkatesha SH; Ramakrishnan C; Nanjaraj Urs AN; Hiremath V; Moudgil KD; Velmurugan D; Vishwanath BS
    Pharmacol Res; 2016 Nov; 113(Pt A):265-275. PubMed ID: 27597642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
    Kong W; Hooper KM; Ganea D
    Brain Behav Immun; 2016 Mar; 53():59-71. PubMed ID: 26541818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrofurandiol stimulation of phospholipase A2, lipoxygenase, and cyclooxygenase gene expression and MCF-7 human breast cancer cell proliferation.
    Markaverich BM; Crowley J; Rodriquez M; Shoulars K; Thompson T
    Environ Health Perspect; 2007 Dec; 115(12):1727-31. PubMed ID: 18087590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavocoxid, a nutraceutical approach to blunt inflammatory conditions.
    Bitto A; Squadrito F; Irrera N; Pizzino G; Pallio G; Mecchio A; Galfo F; Altavilla D
    Mediators Inflamm; 2014; 2014():790851. PubMed ID: 25242871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
    Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
    Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.
    Meshram MA; Bhise UO; Makhal PN; Kaki VR
    Eur J Med Chem; 2021 Dec; 225():113804. PubMed ID: 34479036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24R,25-(OH)(2)D(3) mediates its membrane receptor-dependent effects on protein kinase C and alkaline phosphatase via phospholipase A(2) and cyclooxygenase-1 but not cyclooxygenase-2 in growth plate chondrocytes.
    Schwartz Z; Sylvia VL; Del Toro F; Hardin RR; Dean DD; Boyan BD
    J Cell Physiol; 2000 Mar; 182(3):390-401. PubMed ID: 10653606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer.
    Aliabadi A; Khanniri E; Mahboubi-Rabbani M; Bayanati M
    Eur J Med Chem; 2023 Dec; 261():115866. PubMed ID: 37862815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodioxole-Pyrazole Hybrids as Anti-Inflammatory and Analgesic Agents with COX-1,2/5-LOX Inhibition and Antioxidant Potential.
    Abd El Razik HA; Badr MH; Atta AH; Mouneir SM; Abu-Serie MM
    Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28418202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors.
    Sud'ina GF; Pushkareva MA; Shephard P; Klein T
    Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):99-108. PubMed ID: 18280718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.